APA (7th ed.) Citation

ND, M., SM, S., M, B., NM, K., A, R., FW, R., . . . AM, H. (2024). Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data Availability. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 42(32), 3773. https://doi.org/10.1200/JCO.24.00539

Chicago Style (17th ed.) Citation

ND, Modi, Swain SM, Buyse M, Kuderer NM, Rowland A, Rockhold FW, Sorich MJ, and Hopkins AM. "Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data Availability." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 42, no. 32 (2024): 3773. https://doi.org/10.1200/JCO.24.00539.

MLA (9th ed.) Citation

ND, Modi, et al. "Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data Availability." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 42, no. 32, 2024, p. 3773, https://doi.org/10.1200/JCO.24.00539.